RESPONSE: A Placebo-controlled, Randomized, Phase 3 Study to Evaluate the Efficacy and Safety of Seladelpar in Patients With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

Project: Research

Project Details

StatusFinished
Effective start/end date16/07/21 → 31/12/24

Keywords

  • Gastroenterology
  • Primary Biliary Cholangitis
  • Clinical trial